Overview

Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

Status:
Enrolling by invitation
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
This trial is conducted in North America. The aim is to investigate timely detection of pancreatitis cases as well as cases of suspicion of serious and non-serious adverse reactions possibly or probably related to Saxenda® in Mexican patients.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide